Medication Adherence and Risk of Hospitalization in Pulmonary Arterial Hypertension (PAH) Patients Treated with Endothelin Receptor Antagonists (ERAS) or Phosphodiesterase Type 5 Inhibitors (PDE5IS)
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.1347
https://www.valueinhealthjournal.com/article/S1098-3015(17)31681-9/fulltext
Title :
Medication Adherence and Risk of Hospitalization in Pulmonary Arterial Hypertension (PAH) Patients Treated with Endothelin Receptor Antagonists (ERAS) or Phosphodiesterase Type 5 Inhibitors (PDE5IS)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31681-9&doi=10.1016/j.jval.2017.08.1347
First page :
A620
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1202